PDCD1 and colorectal carcinoma: To explore the effectiveness of ICB combinations in a human context, we conducted experiments using patient-derived MMRd CRC spheroids with immune infiltration and stimulation using anti-PD-1, anti-TIM3, and anti-LAG3.